• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自非离子表面活性剂囊泡凝胶体系的熊果酸的透皮电位及抗关节炎功效

Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems.

作者信息

Jamal Mahvish, Imam Syed Sarim, Aqil Mohd, Amir Mohd, Mir Shaukat R, Mujeeb Mohd

机构信息

Faculty of Pharmacy, Jamia Hamdard University, New Delhi, India.

Glocal School of Pharmacy, Glocal University, Saharanpur, Uttar Pradesh, India.

出版信息

Int Immunopharmacol. 2015 Dec;29(2):361-369. doi: 10.1016/j.intimp.2015.10.029. Epub 2015 Nov 3.

DOI:10.1016/j.intimp.2015.10.029
PMID:26545446
Abstract

The aim of the present study was to optimize niosomes by experimental design for enhanced transdermal delivery of ursolic acid for the effective treatment of arthritis. The experimental design (3 factor 3 levels, Box-Behnken design) was used to study individual and combined effects of different formulation variables. The variables cholesterol (X1), span 60 (X2) and phospholipid (X3) were taken as independent factors and their effect was observed on size (Y1) entrapment efficiency (Y2), and transflux (Y3). The formulation composition with span 60 (85mg), cholesterol (12.3mg), and phospholipid (65mg) was found to fulfil requisites of optimized ursolic acid niosome formulation (URNF). URNF had shown vesicle size of 665.45nm, entrapment efficiency of 92.74% with transflux of 17.25μg/cm(2)/h. The in vivo bioactivity showed that the prepared URNF-gel was able to provide good anti-arthritic activity due to enhanced permeation of UA through the skin and results were found to be comparable to standard gel (Omni gel). The radiographical image confirmed that, the developed URNF-gel was found to be effective to treat arthritis. Thus niosomal gel of ursolic acid would be a promising alternative to conventional therapy for safe and efficient treatment of arthritis and musculoskeletal disorders.

摘要

本研究的目的是通过实验设计优化非离子表面活性剂囊泡,以增强熊果酸的透皮递送,从而有效治疗关节炎。采用实验设计(3因素3水平,Box-Behnken设计)来研究不同制剂变量的单独和联合作用。将变量胆固醇(X1)、司盘60(X2)和磷脂(X3)作为独立因素,并观察它们对粒径(Y1)、包封率(Y2)和通量(Y3)的影响。发现含有司盘60(85mg)、胆固醇(12.3mg)和磷脂(65mg)的制剂组成满足优化的熊果酸非离子表面活性剂囊泡制剂(URNF)的要求。URNF的囊泡粒径为665.45nm,包封率为92.74%,通量为17.25μg/cm²/h。体内生物活性表明,制备的URNF凝胶能够提供良好的抗关节炎活性,这是由于熊果酸经皮渗透增强,结果发现与标准凝胶(全效凝胶)相当。影像学图像证实,所开发的URNF凝胶被发现对治疗关节炎有效。因此,熊果酸非离子表面活性剂囊泡凝胶将是传统疗法的一个有前途的替代方案,用于安全有效地治疗关节炎和肌肉骨骼疾病。

相似文献

1
Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems.来自非离子表面活性剂囊泡凝胶体系的熊果酸的透皮电位及抗关节炎功效
Int Immunopharmacol. 2015 Dec;29(2):361-369. doi: 10.1016/j.intimp.2015.10.029. Epub 2015 Nov 3.
2
Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.熊果酸富集的神圣罗勒(Ocimum sanctum L.)叶提取物负载的纳米结构脂质载体通过抑制 COX-1、COX-2、TNF-α 和 IL-1 改善大鼠佐剂性关节炎:药理学和对接研究。
PLoS One. 2018 Mar 20;13(3):e0193451. doi: 10.1371/journal.pone.0193451. eCollection 2018.
3
Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.载拉西地平的尼奥斯omal 凝胶透皮给药的制剂及优化:体外特性及体内活性。
Biomed Pharmacother. 2017 Sep;93:255-266. doi: 10.1016/j.biopha.2017.06.043. Epub 2017 Jul 18.
4
Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment.非离子表面活性剂囊泡增强叶黄素的透皮传递:质量评价和抗关节炎评估。
Drug Deliv. 2016;23(3):1079-84. doi: 10.3109/10717544.2014.945130. Epub 2014 Aug 12.
5
Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.用于增强氯诺昔康经皮递送的脂质体凝胶制剂:体外和体内评价
Curr Drug Deliv. 2018;15(1):122-133. doi: 10.2174/1567201814666170224141548.
6
Preparation and evaluation of optimized zolmitriptan niosomal emulgel.优化佐米曲普坦尼莫司囊泡乳凝胶的制备与评价。
Drug Dev Ind Pharm. 2019 Jul;45(7):1157-1167. doi: 10.1080/03639045.2019.1601737. Epub 2019 May 15.
7
Development and optimization of boswellic acid-loaded proniosomal gel.载乳香酸前体脂质体凝胶的研制与优化
Drug Deliv. 2016 Oct;23(8):3072-3081. doi: 10.3109/10717544.2016.1149744. Epub 2016 Mar 8.
8
Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.用于强化银屑病治疗的局部用载甲氨蝶呤脂质体的设计与优化:Box-Behnken设计的应用、体外评价及体内皮肤沉积研究
Int J Pharm. 2015 May 15;485(1-2):235-43. doi: 10.1016/j.ijpharm.2015.03.020. Epub 2015 Mar 12.
9
Proniosomal formulation of curcumin having anti-inflammatory and anti-arthritic activity in different experimental animal models.姜黄素的前体脂质体制剂在不同实验动物模型中具有抗炎和抗关节炎活性。
Pharmazie. 2012 Oct;67(10):852-7.
10
Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.含异桉叶油醇作为新型渗透促进剂的缬沙坦透皮凝胶的设计、配方及优化:Wistar白化大鼠药代动力学的临床前评估
Expert Opin Drug Deliv. 2014 Aug;11(8):1149-62. doi: 10.1517/17425247.2014.914027. Epub 2014 May 15.

引用本文的文献

1
A Comprehensive Review on Recent Advances and Patents of Niosomes.关于非离子表面活性剂囊泡的最新进展与专利的综合综述
Recent Pat Nanotechnol. 2025;19(3):364-380. doi: 10.2174/0118722105259776231002071218.
2
Phytoconstituents-Based Nanotherapeutic Approach for the Effective Management of Joint Inflammatory Condition: Arthritis.基于植物成分的纳米治疗方法在关节炎症性疾病(关节炎)的有效管理中的应用。
Curr Drug Targets. 2024;25(10):700-714. doi: 10.2174/0113894501306516240531053653.
3
Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds.
脂质体作为一种提高抗炎化合物有效性的有前景的工具。
EXCLI J. 2024 Feb 7;23:212-263. doi: 10.17179/excli2023-6868. eCollection 2024.
4
Triterpenes Drug Delivery Systems, a Modern Approach for Arthritis Targeted Therapy.三萜类药物递送系统,一种用于关节炎靶向治疗的现代方法。
Pharmaceuticals (Basel). 2023 Dec 28;17(1):54. doi: 10.3390/ph17010054.
5
A Comprehensive Review on Niosomes as a Strategy in Targeted Drug Delivery: Pharmaceutical, and Herbal Cosmetic Applications.载药囊泡作为靶向药物传递策略的综合评价:药物制剂和草药化妆品应用。
Curr Drug Deliv. 2024;21(11):1460-1473. doi: 10.2174/0115672018269199231121055548.
6
From Plants to Wound Dressing and Transdermal Delivery of Bioactive Compounds.从植物到伤口敷料及生物活性化合物的透皮递送
Plants (Basel). 2023 Jul 16;12(14):2661. doi: 10.3390/plants12142661.
7
A Comprehensive Review on Niosomes as a Tool for Advanced Drug Delivery.载药囊泡作为高级药物传递工具的全面综述。
Pharm Nanotechnol. 2024;12(3):206-228. doi: 10.2174/2211738511666230726154557.
8
Biocatalysis of ursolic acid by the fungus CGMCC 3.3657 and resulting anti-HCV activity.真菌CGMCC 3.3657对熊果酸的生物催化及由此产生的抗丙型肝炎病毒活性。
RSC Adv. 2018 May 3;8(29):16400-16405. doi: 10.1039/c8ra01217b. eCollection 2018 Apr 27.
9
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.天然抗癌化合物:源自中草药的光芒。
Chin Med. 2019 Nov 6;14:48. doi: 10.1186/s13020-019-0270-9. eCollection 2019.
10
Essential Oils and Isolated Terpenes in Nanosystems Designed for Topical Administration: A Review.纳米系统中的精油和分离萜烯用于局部给药:综述。
Biomolecules. 2019 Apr 5;9(4):138. doi: 10.3390/biom9040138.